Reporting period January – March · Order intake increased by 20.3% to SEK 7,192 M (5,977), and grew organically by 2.2% · Net sales rose by 19.2% to SEK 6,712 M (5,632), and grew organically by 1.4% · Profit before tax increased to SEK 146 M (-452) · Net profit increased to SEK 107 M (-330) · Earnings per share amounted to SEK 0.38 (-1.39) · EBITA before restructuring costs increased by 7.0% to SEK 717 M (670) · Operating cash flow increased by 49.3% to SEK 654 M (438) · Agreement concerning Consent Decree with US FDA
Getinge Group Interim report January – March 2015
| Source: Getinge AB